导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -15.78% | 909/1050 |
| 近一周 | -2.15% | 380/1104 |
| 近一月 | -2.95% | 233/1102 |
| 近一季 | 4.93% | 127/1092 |
| 近半年 | -13.15% | 810/1070 |
| 近一年 | -25.61% | 959/1018 |
| 近两年 | -5.54% | 900/926 |
| 近三年 | -29.44% | 807/834 |
| 成立以来 | 34.16% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-8.05% 955/1070 |
-13.80% 998/1101 |
- - |
- - |
| 2025 | -1.09% 939/1065 |
2.52% 604/1014 |
-0.43% 723/1038 |
4.99% 935/1050 |
-7.71% 826/1065 |
| 2024 | -11.54% 798/1011 |
-0.75% 353/960 |
-7.56% 769/983 |
8.71% 741/991 |
-11.32% 935/1011 |
| 2023 | -16.69% 588/952 |
1.10% 568/880 |
-9.49% 750/895 |
-6.67% 402/915 |
-2.46% 266/952 |
| 2022 | -29.58% 619/867 |
-24.13% 709/773 |
11.17% 219/806 |
-16.33% 641/845 |
-0.20% 452/867 |
| 2021 | -2.55% 390/740 |
0.18% 145/580 |
7.56% 419/659 |
-16.06% 627/704 |
7.74% 130/740 |
| 2020 | 52.19% 231/554 |
13.44% 23/419 |
35.74% 63/466 |
3.55% 380/517 |
-4.56% 512/554 |
| 2019 | 71.03% 37/410 |
39.91% 65/1146 |
4.88% 45/1228 |
1.02% 308/390 |
15.38% 48/410 |
| 2018 | -17.31% 42/349 |
- - |
6.15% 15/990 |
-7.67% 637/1000 |
-12.87% 712/1080 |
| 2017 | 30.71% 38/285 |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 中欧消费主题股票C VS. 东吴新产业精选股票A(580008) |